JP2010500286A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010500286A5 JP2010500286A5 JP2009521936A JP2009521936A JP2010500286A5 JP 2010500286 A5 JP2010500286 A5 JP 2010500286A5 JP 2009521936 A JP2009521936 A JP 2009521936A JP 2009521936 A JP2009521936 A JP 2009521936A JP 2010500286 A5 JP2010500286 A5 JP 2010500286A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- rapamycin analog
- acetate
- powder
- ray diffraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims 16
- 239000000203 mixture Substances 0.000 claims 14
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical class C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 claims 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims 6
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 claims 6
- 238000000634 powder X-ray diffraction Methods 0.000 claims 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 5
- SYBYTAAJFKOIEJ-UHFFFAOYSA-N 3-Methylbutan-2-one Chemical compound CC(C)C(C)=O SYBYTAAJFKOIEJ-UHFFFAOYSA-N 0.000 claims 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 claims 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 4
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims 4
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 claims 4
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims 4
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 claims 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 4
- 239000013078 crystal Substances 0.000 claims 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims 2
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 claims 2
- GJRQTCIYDGXPES-UHFFFAOYSA-N iso-butyl acetate Natural products CC(C)COC(C)=O GJRQTCIYDGXPES-UHFFFAOYSA-N 0.000 claims 2
- FGKJLKRYENPLQH-UHFFFAOYSA-M isocaproate Chemical compound CC(C)CCC([O-])=O FGKJLKRYENPLQH-UHFFFAOYSA-M 0.000 claims 2
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 claims 2
- 229940011051 isopropyl acetate Drugs 0.000 claims 2
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 claims 2
- OQAGVSWESNCJJT-UHFFFAOYSA-N isovaleric acid methyl ester Natural products COC(=O)CC(C)C OQAGVSWESNCJJT-UHFFFAOYSA-N 0.000 claims 2
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 claims 2
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 claims 2
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 claims 2
- YKYONYBAUNKHLG-UHFFFAOYSA-N propyl acetate Chemical compound CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 229940002612 prodrug Drugs 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82031706P | 2006-07-25 | 2006-07-25 | |
| US11/781,807 US7820812B2 (en) | 2006-07-25 | 2007-07-23 | Methods of manufacturing crystalline forms of rapamycin analogs |
| US11/781,804 US7812032B2 (en) | 2006-07-25 | 2007-07-23 | Crystalline forms of rapamycin analogs |
| PCT/US2007/074159 WO2008014222A1 (en) | 2006-07-25 | 2007-07-24 | Crystalline forms of rapamycin analogs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010500286A JP2010500286A (ja) | 2010-01-07 |
| JP2010500286A5 true JP2010500286A5 (enExample) | 2010-09-09 |
Family
ID=38562825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009521936A Pending JP2010500286A (ja) | 2006-07-25 | 2007-07-24 | 結晶形態のラパマイシン類似体 |
Country Status (10)
| Country | Link |
|---|---|
| EP (2) | EP2051984A1 (enExample) |
| JP (1) | JP2010500286A (enExample) |
| KR (1) | KR20090035716A (enExample) |
| AU (1) | AU2007276837B2 (enExample) |
| BR (1) | BRPI0714945B8 (enExample) |
| CA (1) | CA2658896A1 (enExample) |
| IL (1) | IL196706A0 (enExample) |
| MX (1) | MX2009001067A (enExample) |
| NZ (1) | NZ574654A (enExample) |
| WO (1) | WO2008014222A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7812032B2 (en) | 2006-07-25 | 2010-10-12 | Abbott Laboratories | Crystalline forms of rapamycin analogs |
| US7820812B2 (en) | 2006-07-25 | 2010-10-26 | Abbott Laboratories | Methods of manufacturing crystalline forms of rapamycin analogs |
| KR20120106880A (ko) | 2007-01-21 | 2012-09-26 | 헤모텍 아게 | 체강의 협착 치료 및 급성 재협착 예방을 위한 의료 제품 |
| US9192697B2 (en) | 2007-07-03 | 2015-11-24 | Hemoteq Ag | Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis |
| JP5643770B2 (ja) * | 2009-01-21 | 2014-12-17 | バイオコン・リミテッドＢｉｏｃｏｎ Ｌｉｍｉｔｅｄ | シロリムスの安定性の決定方法およびその安定形態の調製方法 |
| EP2451496B1 (en) | 2009-07-10 | 2015-07-22 | Boston Scientific Scimed, Inc. | Use of nanocrystals for a drug delivery balloon |
| WO2011008393A2 (en) | 2009-07-17 | 2011-01-20 | Boston Scientific Scimed, Inc. | Nucleation of drug delivery balloons to provide improved crystal size and density |
| WO2012031236A1 (en) | 2010-09-02 | 2012-03-08 | Boston Scientific Scimed, Inc. | Coating process for drug delivery balloons using heat-induced rewrap memory |
| US8669360B2 (en) | 2011-08-05 | 2014-03-11 | Boston Scientific Scimed, Inc. | Methods of converting amorphous drug substance into crystalline form |
| US9056152B2 (en) | 2011-08-25 | 2015-06-16 | Boston Scientific Scimed, Inc. | Medical device with crystalline drug coating |
| US9439892B2 (en) | 2013-05-16 | 2016-09-13 | Surmodics, Inc. | Macrolide particulates, methods for preparation, and medical devices associated therewith |
| US9770537B2 (en) | 2013-06-12 | 2017-09-26 | Surmodics, Inc. | Solvent methods for preparing crystalline macrolide particulates, compositions, and articles containing particulates |
| DE102013110294B4 (de) * | 2013-09-18 | 2016-07-07 | Innora Gmbh | Limus-Depot-Formulierung auf Ballonkathetern |
| US10098846B2 (en) | 2016-03-31 | 2018-10-16 | Surmodics, Inc. | Drug-containing particulate composition with cationic agent, associated medical devices, and methods for treatment |
| US11123459B2 (en) | 2016-12-16 | 2021-09-21 | Surmodics, Inc. | Hydrophobic active agent particle coatings and methods for treatment |
| CN108144131A (zh) * | 2017-12-22 | 2018-06-12 | 上海微创医疗器械（集团）有限公司 | 一种载药植入医疗器械及其制备方法 |
| JP2023519875A (ja) * | 2020-03-27 | 2023-05-15 | ボストン サイエンティフィック サイムド，インコーポレイテッド | 薬品の結晶化のための方法 |
| EP4281463A4 (en) * | 2021-01-22 | 2025-07-23 | Janssen Pharmaceutica Nv | RAPAMYCIN ANALOGUES AND THEIR USES |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5527907A (en) | 1993-11-19 | 1996-06-18 | Abbott Laboratories | Macrolide immunomodulators |
| US6015815A (en) * | 1997-09-26 | 2000-01-18 | Abbott Laboratories | Tetrazole-containing rapamycin analogs with shortened half-lives |
| US20030129215A1 (en) * | 1998-09-24 | 2003-07-10 | T-Ram, Inc. | Medical devices containing rapamycin analogs |
| TW557297B (en) * | 1997-09-26 | 2003-10-11 | Abbott Lab | Rapamycin analogs having immunomodulatory activity, and pharmaceutical compositions containing same |
| SK9742002A3 (en) * | 2000-01-07 | 2003-02-04 | Transform Pharmaceuticals Inc | High-throughput formation, identification, and analysis of diverse solid-forms |
| AR050374A1 (es) * | 2004-08-20 | 2006-10-18 | Wyeth Corp | Forma polimorfica de rafampicina |
| TW200628483A (en) * | 2004-12-01 | 2006-08-16 | Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag | Processes for producing crystalline macrolides |
-
2007
- 2007-07-24 AU AU2007276837A patent/AU2007276837B2/en active Active
- 2007-07-24 EP EP07799771A patent/EP2051984A1/en not_active Withdrawn
- 2007-07-24 CA CA002658896A patent/CA2658896A1/en not_active Abandoned
- 2007-07-24 JP JP2009521936A patent/JP2010500286A/ja active Pending
- 2007-07-24 WO PCT/US2007/074159 patent/WO2008014222A1/en not_active Ceased
- 2007-07-24 EP EP11183446A patent/EP2407471A3/en not_active Withdrawn
- 2007-07-24 MX MX2009001067A patent/MX2009001067A/es active IP Right Grant
- 2007-07-24 NZ NZ574654A patent/NZ574654A/en unknown
- 2007-07-24 KR KR1020097003955A patent/KR20090035716A/ko not_active Ceased
- 2007-07-24 BR BRPI0714945A patent/BRPI0714945B8/pt active IP Right Grant
-
2009
- 2009-01-25 IL IL196706A patent/IL196706A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010500286A5 (enExample) | ||
| JP2010536889A5 (enExample) | ||
| RU2009106470A (ru) | Кристаллические формы аналогов рапамицина | |
| JP2019514874A5 (enExample) | ||
| JP2010504343A5 (enExample) | ||
| JP2009530283A5 (enExample) | ||
| JP2005053931A5 (enExample) | ||
| JP2010540541A5 (enExample) | ||
| JP2009263394A5 (enExample) | ||
| JP2010090149A5 (enExample) | ||
| JP2013505929A5 (enExample) | ||
| HRP20141137T1 (hr) | Polimorfni oblici macrocikliäśkog inhibitora hcv | |
| JP2015508092A5 (enExample) | ||
| RU2018145948A (ru) | Кристалл пирролопиримидина для получения jak-ингибитора | |
| JP2011518775A5 (enExample) | ||
| JP2010536766A5 (enExample) | ||
| JP2011500513A5 (enExample) | ||
| JP2008546770A5 (enExample) | ||
| JP2012092103A5 (enExample) | ||
| JP2012512863A5 (enExample) | ||
| JP2014518240A5 (enExample) | ||
| US20200347047A1 (en) | Solid state form of valbenazine | |
| JP2010534246A5 (enExample) | ||
| JP2010508310A5 (enExample) | ||
| JP2014530818A5 (enExample) |